| NCT ID | NCT07305753 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pennington Biomedical Research Center |
| Condition | Healthy Participants |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-10-15 |
| Primary Completion | 2026-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-10-15 with a primary completion date of 2026-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to develop a dataset with reference body composition measurements using criterion methods. This dataset will be used to develop new protocols to study patients with cancer. Obtaining measurements of sodium bromide (NaBr), deuterium dilution (D2O), and D3-Creatine in a stratified sample of adults will determine the accuracy (and precision) of the available devices for ECW, TBW, and skeletal muscle mass measurements.
Eligibility Criteria
Inclusion Criteria: * Being either male or female * Being an adult \>20 - \<40 or \>70 years of age. * Having a body weight of less than 440 pounds * Being willing to comply with the study procedures * Not having a chronic illness (e.g., diabetes, cancer, etc.) * Must be willing to have biospecimens and imaging stored for research use Exclusion Criteria: * Being pregnant, attempting to become pregnant, or breastfeeding * Having medical implants such as a pacemaker or metal joint replacements * Having had a mastectomy, breast reduction, or breast implants * Having hair that cannot fit in a swim cap * Having a body weight greater than 440 pounds * Taking medications that alter the body's fluid compartments (ex: diuretics) * Not willing to have biospecimens and imaging stored for future research use.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07305753 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 90 Years, studying Healthy Participants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07305753 currently recruiting?
Yes, NCT07305753 is actively recruiting participants. Contact the research team at steven.heymsfield@pbrc.edu for enrollment information.
Where is the NCT07305753 trial being conducted?
This trial is being conducted at Baton Rouge, United States.
Who is sponsoring the NCT07305753 clinical trial?
NCT07305753 is sponsored by Pennington Biomedical Research Center. The trial plans to enroll 40 participants.